Feminist Majority Foundation (publisher of Ms.) led the campaign to win FDA approval of mifepristone for early medical abortion from 1989 until victory on September 28, 2000. Today some 40% of […]
Author: Beth Jordan
Dr. Beth Jordan is a women’s health specialist with extensive experience providing care to women with breast cancer, ovarian cancer, unwanted pregnancy, endometriosis and uterine fibroid tumors amongst a myriad of other conditions that could benefit from additional research on mifepristone.